Literature DB >> 7671924

The long term prognosis of infective endocarditis.

F Delahaye1, R Ecochard, G de Gevigney, C Barjhoux, V Malquarti, W Saradarian, J Delaye.   

Abstract

Three problems hamper the prognosis of patients who survive the initial phase of infective endocarditis (IE): the rate of IE recurrence is 0.3-2.5/100 patient years, about 60% of patients will have to be operated on at some time, 20-30% during the initial stay, 30-40% during the following 5-8 years; five-year survival after the hospital phase is about 75% in previous reports and 85% in more recent papers. Death is mainly due to heart failure. We looked at the long-term survival of 330 patients with IE who were hospitalized in our institution in 1970-1982, and at the potential influence of 10 factors: age, gender, previous heart disease, microorganism, location of IE, onset of IE, congestive heart failure (CHF) at onset, CHF during the first year, persistent fever, surgery at the acute phase. Global survival was 75% at 6 months, and 57% at 5 years. The only non-significant factor was IE location. The annual instantaneous risk of death was 0.55 at 6 months, 0.18 at 1 year, then 0.03. After one year, the only prognostic factor was age. The relative risk of dying among patients with IE who survived the first year, as compared to the risk of dying among the general population, was 3.27. The IE prognosis is not uniform. Mortality is high during the initial phase, but after one year the risk of dying is low, although still above that of the general population. Part of the risk is probably the direct consequence of IE, but part is due to the course of the underlying heart disease.

Entities:  

Mesh:

Year:  1995        PMID: 7671924     DOI: 10.1093/eurheartj/16.suppl_b.48

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  [Prophylaxis of bacterial endocarditis].

Authors:  T Greten; F von Hoch; J Ennker; E von Hodenberg
Journal:  Z Kardiol       Date:  2001-12

2.  Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study.

Authors:  J C Castillo; M P Anguita; A Ramírez; J R Siles; F Torres; D Mesa; M Franco; I Muñoz; M Concha; F Vallés
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

3.  Comparison of long term outcome in patients with or without aortic ring abscess treated surgically for aortic valve infective endocarditis.

Authors:  N Danchin; G Retournay; O Stchepinsky; C Selton-Suty; P Voiriot; B Hoen; P Canton; J P Villemot; P Mathieu; F Cherrier
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

4.  Infective endocarditis: determinants of long term outcome.

Authors:  R O M Netzer; S C Altwegg; E Zollinger; M Täuber; T Carrel; C Seiler
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

5.  Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve Surgery.

Authors:  Jinnam Kim; Jung Ho Kim; Hi Jae Lee; Se Ju Lee; Ki Hyun Lee; Eun Hwa Lee; Yae Jee Baek; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Seung Hyun Lee; Jun Yong Choi; Joon-Sup Yeom
Journal:  Infect Dis Ther       Date:  2022-04-30

6.  Short-term and one-year outcome of infective endocarditis in adult patients treated in a Finnish teaching hospital during 1980-2004.

Authors:  Maija Heiro; Hans Helenius; Saija Hurme; Timo Savunen; Erik Engblom; Jukka Nikoskelainen; Pirkko Kotilainen
Journal:  BMC Infect Dis       Date:  2007-07-17       Impact factor: 3.090

7.  Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years.

Authors:  Maija Heiro; Hans Helenius; Saija Hurme; Timo Savunen; Kaj Metsärinne; Erik Engblom; Jukka Nikoskelainen; Pirkko Kotilainen
Journal:  BMC Infect Dis       Date:  2008-04-17       Impact factor: 3.090

8.  Twenty-Year Experience in the Diagnosis and Treatment of Infective Endocarditis.

Authors:  Elżbieta Abramczuk; Janina Stępińska; Tomasz Hryniewiecki
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

9.  A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden.

Authors:  Anders Ternhag; Agneta Cederström; Anna Törner; Katarina Westling
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

Review 10.  The global burden of congenital heart disease.

Authors:  Julien Ie Hoffman
Journal:  Cardiovasc J Afr       Date:  2013-05       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.